Literature DB >> 14663011

Caffeinated clues from epidemiology of Parkinson's disease.

Alberto Ascherio1, Honglei Chen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14663011     DOI： 10.1212/01.wnl.0000095213.86899.21

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  9 in total

Review 1.  Treatment of Parkinson's disease : what's on the horizon?

Authors:  Stacy S Wu; Steven J Frucht
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 2.  Coffee, tea, and caffeine consumption and prevention of late-life cognitive decline and dementia: a systematic review.

Authors:  F Panza; V Solfrizzi; M R Barulli; C Bonfiglio; V Guerra; A Osella; D Seripa; C Sabbà; A Pilotto; G Logroscino
Journal:  J Nutr Health Aging       Date:  2015-03       Impact factor: 4.075

Review 3.  Psychostimulants and cognition: a continuum of behavioral and cognitive activation.

Authors:  Suzanne Wood; Jennifer R Sage; Tristan Shuman; Stephan G Anagnostaras
Journal:  Pharmacol Rev       Date:  2013-12-16       Impact factor: 25.468

4.  Association of adenosine receptor gene polymorphisms and in vivo adenosine A1 receptor binding in the human brain.

Authors:  Christa Hohoff; Valentina Garibotto; David Elmenhorst; Anna Baffa; Tina Kroll; Alana Hoffmann; Kathrin Schwarte; Weiqi Zhang; Volker Arolt; Jürgen Deckert; Andreas Bauer
Journal:  Neuropsychopharmacology       Date:  2014-06-19       Impact factor: 7.853

5.  Caffeine for treatment of Parkinson disease: a randomized controlled trial.

Authors:  Ronald B Postuma; Anthony E Lang; Renato P Munhoz; Katia Charland; Amelie Pelletier; Mariana Moscovich; Luciane Filla; Debora Zanatta; Silvia Rios Romenets; Robert Altman; Rosa Chuang; Binit Shah
Journal:  Neurology       Date:  2012-08-01       Impact factor: 9.910

6.  Synthesis and Characterization of a New Bivalent Ligand Combining Caffeine and Docosahexaenoic Acid.

Authors:  Víctor Fernández-Dueñas; Jhonny Azuaje; Xavier Morató; Begoña Cordobilla; Joan Carles Domingo; Eddy Sotelo; Francisco Ciruela
Journal:  Molecules       Date:  2017-02-27       Impact factor: 4.411

7.  Quantification of Blood Caffeine Levels in Patients With Parkinson's Disease and Multiple System Atrophy by Caffeine ELISA.

Authors:  Takuma Ohmichi; Takashi Kasai; Makiko Shinomoto; Jun Matsuura; Takashi Koizumi; Fukiko Kitani-Morii; Harutsugu Tatebe; Hidenao Sasaki; Toshiki Mizuno; Takahiko Tokuda
Journal:  Front Neurol       Date:  2020-12-22       Impact factor: 4.003

8.  Biomarker repurposing: Therapeutic drug monitoring of serum theophylline offers a potential diagnostic biomarker of Parkinson's disease.

Authors:  Takuma Ohmichi; Takashi Kasai; Tadashi Kosaka; Keisuke Shikata; Harutsugu Tatebe; Ryotaro Ishii; Makiko Shinomoto; Toshiki Mizuno; Takahiko Tokuda
Journal:  PLoS One       Date:  2018-07-25       Impact factor: 3.240

9.  Effect of single caffeine intake on neuropsychological functions in healthy volunteers: A double-blind placebo-controlled study.

Authors:  Yuki Konishi; Hikaru Hori; Kenta Ide; Asuka Katsuki; Kiyokazu Atake; Ryohei Igata; Takamitsu Kubo; Hirotaka Tominaga; Hiroki Beppu; Toshio Asahara; Reiji Yoshimura
Journal:  PLoS One       Date:  2018-10-31       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.